Markers of fibrosis and epithelial to mesenchymal transition demonstrate field cancerization in histologically normal tissue adjacent to breast tumors
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Previous studies have shown that a field of genetically altered but histologically normal tissue extends 1 cm or more from the margins of human breast tumors. The extent, composition and biological significance of this field are only partially understood, but the molecular alterations in affected cells could provide mechanisms for limitless replicative capacity, genomic instability and a microenvironment that supports tumor initiation and progression. We demonstrate by microarray, qRT‐PCR and immunohistochemistry a signature of differential gene expression that discriminates between patient‐matched, tumor‐adjacent histologically normal breast tissues located 1 cm and 5 cm from the margins of breast adenocarcinomas (TAHN‐1 and TAHN‐5, respectively). The signature includes genes involved in extracellular matrix remodeling, wound healing, fibrosis and epithelial to mesenchymal transition (EMT). Myofibroblasts, which are mediators of wound healing and fibrosis, and intra‐lobular fibroblasts expressing MMP2, SPARC, TGF‐β3, which are inducers of EMT, were both prevalent in TAHN‐1 tissues, sparse in TAHN‐5 tissues, and absent in normal tissues from reduction mammoplasty. Accordingly, EMT markers S100A4 and vimentin were elevated in both luminal and myoepithelial cells, and EMT markers α‐smooth muscle actin and SNAIL were elevated in luminal epithelial cells of TAHN‐1 tissues. These results identify cellular processes that are differentially activated between TAHN‐1 and TAHN‐5 breast tissues, implicate myofibroblasts as likely mediators of these processes, provide evidence that EMT is occurring in histologically normal tissues within the affected field and identify candidate biomarkers to investigate whether or how field cancerization contributes to the development of primary or recurrent breast tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Kim, K. K., Kugler, M. C., Wolters, P. J., Robillard, L., Galvez, M. G., Brumwell, A. N., Sheppard, D., & Chapman, H. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605669103 · Cited by 1,257
Telomere Length Abnormalities Occur Early in the Initiation of Epithelial Carcinogenesis
Meeker, A. K., Hicks, J. L., Iacobuzio-Donahue, C. A., Montgomery, E. A., Westra, W. H., Chan, T. Y., Ronnett, B. M., & De Marzo, A. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0984-03 · Cited by 306 · cited 1×
“Telomere attrition and resulting telomere dysfunction is a significant cause of genomic instability and an early event in breast tumorigenesis.(5,6) Accordingly, allelic imbalance (a form of genomic instability which occurs in virtually all cancers) is 4–5 times more prevalent in TAHN-1 tissues than in patientKey word…”
Background
Cited by
Comprehensive analysis of normal adjacent to tumor transcriptomes
Aran, D., Camarda, R., Odegaard, J., Paik, H., Oskotsky, B., Krings, G., Goga, A., Sirota, M., & Butte, A. J. (2017) · Nature Communications · doi:10.1038/s41467-017-01027-z · Cited by 617
Spatial maps of prostate cancer transcriptomes reveal an unexplored landscape of heterogeneity
Berglund, E., Maaskola, J., Schultz, N., Friedrich, S., Marklund, M., Bergenstråhle, J., Tarish, F., Tanoglidi, A., Vickovic, S., Larsson, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04724-5 · Cited by 562
Nguyen-Ngoc, K.-V., Cheung, K. J., Brenot, A., Shamir, E. R., Gray, R. S., Hines, W. C., Yaswen, P., Werb, Z., & Ewald, A. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1212834109 · Cited by 449
Contribution of adipose tissue to development of cancer
Cozzo, A. J., Fuller, A. M., & Makowski, L. (2017) · Comprehensive Physiology · doi:10.1002/cphy.c170008 · Cited by 188
Guenther, S., Muirhead, L. J., Speller, A. V. M., Golf, O., Strittmatter, N., Ramakrishnan, R., Goldin, R. D., Jones, E., Veselkov, K., Nicholson, J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2258 · Cited by 159
“Both genetic/epigenetic (7-9), and metabolic (10) changes have been demonstrated in the histologically normal tissue surrounding invasive breast cancer compared to distant tissue, or that which has been excised for completely benign disease.”
BackgroundCasbas-Hernandez, P., Fleming, J. M., & Troester, M. A. (2011) · BioMed Research International · doi:10.1155/2011/520987 · Cited by 43
“This extratumoral tissue also provides support for and influences tumor progression, reflecting either a tissue level response to the tumor or the baseline biological behavior of the tissue in which the tumor developed [21].”
BackgroundProteomic Identification of a Gastric Tumor ECM Signature Associated With Cancer Progression
Moreira, A. M., Ferreira, R. M., Carneiro, P., Figueiredo, J., Osório, H., Barbosa, J., Preto, J., Pinto-do-Ó, P., Carneiro, F., & Seruca, R. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.818552 · Cited by 21
“Although histologically normal, evidence indicate that these adjacent tissues display alterations in gene expression related to fibrosis, wound healing, epithelialto-mesenchymal transition, and ECM remodeling (Troester et al., 2009; Trujillo et al., 2011; Casbas-Hernandez et al., 2015).”
Background
Metadata
- Authors
- Trujillo, K. A., Heaphy, C. M., Mai, M., Vargas, K. M., Jones, A. C., Vo, P., Butler, K. S., Joste, N. E., Bisoffi, M., & Griffith, J. K.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2011-02-11
- Volume
- 129
- Issue
- 6
- Pages
- 1310-1321
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2076061584
- Cited by
- 110
- References
- 4
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.